5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Vijaya Diagnostic Centre Ltd.

•
vijayadiagnostic.comBSE: 543350NSE: VIJAYA
Market Cap₹ 15,473 Cr.
Current Price
High / Low₹ 1,578 / 848
Stock P/E80.3
Book Value₹ 96
Price to Book9.43
Dividend Yield0.13 %
ROCE31.0 %
ROE20.9 %
Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 29.8%
  • Latest quarter profit grew 38.4% YoY, showing strong momentum
  • Company has delivered good sales growth of 15.8% CAGR over last 5 years
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.49x)

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • Stock is trading at 9.4x its book value
  • Recurring exceptional / one-off items are inflating headline profit
  • Though reporting repeated profits, the company pays out little dividend (11.5%)
  • Expensive relative to growth - PEG of 2.8

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcareHospital & Healthcare Services
Part ofNIFTY TOTAL MKTNIFTY 500NIFTY SMLCAP 250NIFTY MULTI MQ 50
S.No.Name
1.APOLLOHOSP8850.0060.90127249.420.23610.4038.417043.5020.5621.7315.70
2.MAXHEALTH1037.2069.29100951.740.19322.964.872366.1716.7014.9725.29
3.MANIPALHOS716.15105.5794200.740.002434.30—30906.30—13.9323.83
4.FORTIS887.3063.9366987.440.11272.802.262545.0317.4614.0721.28
5.ASTERDM762.95208.6966504.250.3929.28-68.701310.6821.6011.2619.53
6.MEDANTA1447.5569.9838920.530.03157.25-1.091304.0526.5019.3821.99
7.NH1867.3546.7638161.310.24207.275.372683.6378.0516.2017.43
8.KIMS768.85158.0632292.200.0037.40-56.001179.5035.3311.5119.03
9.LALPATHLAB1909.4059.1432049.051.071705.001172.397977.001090.9529.5631.03
10.AGARWALEYE507.00108.3316073.230.0055.0244.56614.0225.9716.1427.75
11.VIJAYA1502.3082.5315473.350.1353.1037.61230.9822.8330.2842.66
12.RAINBOW1443.4051.3714660.130.2462.5416.23469.9933.1728.2528.65
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
119136129141142170158162175189193206219
71807884871009597105111110115157
Operating Profit47565157567163656979839162
OPM %40.00%41.41%39.57%40.59%39.12%41.50%39.91%40.10%39.68%41.46%42.82%44.21%28.32%
6733455475679
Interest66666667778910
Depreciation12141415151517171819212122
Profit before Tax35443440385445465257596871
Tax %25.80%24.98%25.38%23.34%24.67%26.23%24.36%26.59%25.56%25.15%25.11%22.87%25.05%
Net Profit26332531294034333843445353
2.553.212.472.982.823.873.283.253.744.154.305.125.17

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
279329367451450525634765807
187196204251271316379443493
Operating Profit92132163200179209255322314
OPM %32.90%40.30%44.46%44.33%39.81%39.81%40.17%42.13%38.93%
91211131523172527
Interest41515162124253134
Depreciation264850526155658084
Profit before Tax7082110144111152183236255
Tax %30.52%25.09%24.42%25.13%25.20%24.84%25.53%24.57%24.50%
Net Profit49618310883115136178193
EPS107.666.008.1210.548.1211.2013.2417.33—
Dividend Payout %0.00%0.00%0.00%9.43%12.26%8.93%15.10%11.54%—

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
16%
3 Years:
19%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
17%
3 Years:
29%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
47%
1 Year:
43%

RETURN ON EQUITY

10 Years:
—
5 Years:
20%
3 Years:
20%
Last Year:
21%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

Sep 16

₹ 2

Rs.2.0000 per share(200%)Final Dividend

2025

Aug 29

₹ 2

Rs.2.0000 per share(200%)Final Dividend

2024

Aug 30

₹ 1

Rs.1.0000 per share(100%)Final Dividend

2023

Sep 13

₹ 1

Rs.1.0000 per share(100%)Dividend

2022

Sep 20

₹ 1

Rs.1.0000 per share(100%)Final Dividend

2026

Aug 20

₹ 2

Rs.2.0000 per share(200%)Final Dividend

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
5551010101010
209273355458533642754930
38149127170233233273379
Trade Payables1819202027313135
222921443944153106
Total Liabilities2924745277038429601,2211,460
137264261353506571673862
Capital Work in Progress398342786734
73583359144254326368
23242444
00000131321
Cash & Bank52114189186111624251
26263567524895119
Total Assets2924745277038429601,2211,460

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
95132159195189175208256
Cash from Investing-91-34-129-127-108-139-167-166
Cash from Financing8-28-48-25-41-43-47-63
-746-49413-8-527

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
53.9353.9153.9153.0552.6352.6052.6052.5152.51
20.0818.1417.5419.3619.5618.2715.1013.3811.65
21.4923.4524.6223.7224.0725.3428.6029.9331.61
Government0.000.000.000.000.000.000.000.000.00
Public4.504.493.923.873.743.793.714.184.23

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-11
General Updates

2026-09-11 - Vijaya Diagnostic Centre Limited has informed the Exchange about General Updates - Investor Presentation - 100% Acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Asssam.

2026-09-11
Press Release

2026-09-11 - Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated September 11, 2026, titled "100% acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Assam.".

2026-09-11
Outcome of Board Meeting

2026-09-11 - Vijaya Diagnostic Centre Limited has informed the Exchange regarding Outcome of Board Meeting held on September 11, 2026. (Approval for execution of Business Transfer Agreement ("BTA") for 100% acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Assam on a slump sale basis subject to the fulfilment of Conditions Precedent (CPs) and other terms and conditions as set out in the BTA.

2026-09-02
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-02 - Vijaya Diagnostic Centre Limited has informed the Exchange about Schedule of meet

2026-09-02
Appointment

2026-09-02 - Vijaya Diagnostic Centre Limited has informed the Exchange regarding Appointment of Mr Venkata Naresh Yallapragada as Other of the company w.e.f. September 02, 2026.

2026-09-02
Change in Management

2026-09-02 - Vijaya Diagnostic Centre Limited has informed the Exchange about change in Management

2026-08-27
Copy of Newspaper Publication

2026-08-27 - Vijaya Diagnostic Centre Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-26
Change in Company Secretary/Compliance Officer

2026-08-26 - Vijaya Diagnostic Centre Limited has informed the Exchange about resignation of Company Secretary/Compliance Officer

2026-08-26
Resignation

2026-08-26 - Vijaya Diagnostic Centre Limited has informed the Exchange regarding Resignation of Mrs. Naga Vasudha Tadepalli as Company Secretary & Compliance Officer of the company w.e.f. August 26, 2026.

News

Recent coverage and analyst commentary for VIJAYA

Loading news…

🤖

AI Stock Analyst

Vijaya Diagnostic Centre Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login